FACIT (Fight Against Cancer Innovation Trust)
Government fundToronto · Pre-Seed–Series B · 16 people tracked
Investment thesis
FACIT focuses on funding and growing Ontario oncology and health innovation ventures to benefit patients and the provincial economy. Established by the Ontario Institute for Cancer Research (OICR), it supports commercialization, technology transfer and development of cancer research, aiming to attract more R&D investment to Ontario and bring the best oncology innovations to market. Its investments have generated partnerships, clinical trials, job creation and leveraged financing across the province. FACIT also runs a pitch competition (Falcons' Fortunes) and awards, and works alongside OICR to advance cancer solutions that help patients live longer, healthier lives.
Source: firm website, verified Aug 3, 2026.
Team · 16 people
from the firm's website & curated & public directories
What they invest in
from 14 of 53 portfolio companiesHealthtech ×11Biotech ×9Medical Devices ×9Deep Tech ×3AI & Machine Learning ×2Digital Health ×2Hardware ×2Cybersecurity ×1
HQs:Canada×3United States×2
Investments · 53 tracked
founders shown can be your intro pathBy year:2026 · 22025 · 12024 · 32022 · 17 dated
Profound Medical develops real-time MRI-guided thermal ultrasound systems for incision-free ablation of abnormal or cancerous tissue.
BiotechDeep TechHealthtechMedical DevicesMississauga
Arun Menawat(CEO and Chairman of the Board)Rashed Dewan(Executive Officer)Mathieu Burtnyk(Chief Operating Officer)
BoardJean-Francois Pariseau(Director)Damian Lamb(Director)William Curran(Director)
Co-investorsCTI Life Sciences Fund L.P.Genesys Capital
Co-investorsCreative Destruction Lab (CDL)
Co-investorsThe Forge Business Incubator
Co-investorsCreative Destruction Lab (CDL)
DNAstack builds Omics AI, a software suite that lets data custodians connect, protect, and share omics and health data across federated networks while enabling researchers to discover, access, and analyze it with AI tools.
AI & Machine LearningBiotechDigital HealthToronto, CA
Miro Cupak(Founder)
Acquired by Fluidigm/Standard BioTools.
Co-investorsPfizer Venture Investments
Acquired by Trillium Therapeutics.
Fusion Pharma develops targeted alpha therapeutics that link alpha-emitting medical isotopes to molecules targeting biomarkers on cancer cell surfaces to selectively kill tumor cells.
BiotechHealthtech
Co-investorsHealthCapLumira VenturesSeroba Life SciencesVenture OntarioYsios CapitalAdams Street Partners+2 more
Co-investorsArchangel Network of Funds
Hyivy Health develops a holistic pelvic health device that treats, monitors, tracks, and helps prevent pelvic floor symptoms, along with connecting patients to clinicians and pelvic floor therapists.
Digital HealthFemTechHealthtechMedical Devices
Rachel Bartholomew(CEO & Founder)inKamyar Rounidej(Former Co-founder & first Chief Technical Officer)
Co-investorsBeresford VenturesThe 51 Ventures
KA Imaging develops X-ray imaging technologies and systems, including dual-energy radiography, phase contrast micro-CT, and amorphous selenium detectors.
HardwareHealthtechMedical DevicesWaterloo, CA
Karim S. Karim(Chief Technology Officer (CTO), Co-founder)Sina Ghanbarzadeh(Co-founder & Design Team Lead)Amol Karnick(President & CEO)Philip Templeton(Chief Medical Officer (CMO))
Co-investorsIn-Q-TelLauder Partners
Vancouver
Caroline Stout(Director)Bernard Lam(Executive Officer)Kamran Alam(Executive Officer)Ulrik Nielsen(Director)Heather Lee(Director)Emily Titus(Executive Officer)
Privacy Analytics provides data anonymization technology, advisory services, and tailored solutions to help organizations safely combine, share, and reuse sensitive personal data while managing privacy risk and meeting regulatory requirements.
CybersecurityData & InfrastructureHealthtech
Co-investorsVanedge CapitalVanedge Capital Limited Partnership
ProTgen is a clinical-stage biotechnology company developing targeted Notch activators that generate progenitor T cells to restore thymic function and adaptive immune competence.
BiotechHealthtechToronto
Juan Carlos Zuniga-Pflucker(Executive Officer, Director)
BoardFei Shen(Director)Ferdinand Massari(Director)
Co-investorsEisai Innovation, Inc.
Qurcan develops veterinary pharmaceutical technology, with leadership holding advanced degrees in veterinary medicine, pharmaceutical sciences, and business development.
BiotechDeep TechHealthtechMedical DevicesCambridge, US
Mohammad Ali Amini(Chief Executive Officer)Shirley Wu(Chief Scientific Officer)John Reid(Chief Business Officer)
Co-investorsToronto Innovation Acceleration Partners
Radialis develops the Radialis PET Imager, an organ-targeted positron emission tomography system for high-resolution medical imaging of specific tissues and organs.
Deep TechHealthtechMedical Devices
Alla ReznikAndrew DeanCarmel Shields
BoardWayne Schnarr
Co-investorsToronto Innovation Acceleration Partners
Radiant Biotherapeutics develops a platform of therapeutic molecules called Multabodies that engage multiple disease targets simultaneously within a single engineered protein to treat cancer and infectious diseases.
BiotechMedical Devices
Arthur Fratamico(Executive Officer, Promoter)Deborah Geraghty, Ph.D.(President and Chief Executive Officer)
Co-investorsToronto Innovation Acceleration Partners
Tenomix develops intelligent automation technology for cancer diagnostics and healthcare labs to improve diagnostic speed and accuracy while addressing staffing shortages and rising patient caseloads.
AI & Machine LearningHealthtechMedical DevicesRoboticsLondon, CA
Dr. (unnamed - identified as founder with Ph.D. in Pathology and Laboratory Medicine)(Founder & CEO)Dr. (unnamed - identified as physician-scientist with MD and PhD)(Co-founder)
BiotechNew York, US
Michael Burgess(Executive Officer)Jose Manuel Otero(Executive Officer)Robert Gould(Director)Jane Henderson(Executive Officer)Stefan Larson(Director)Patrick Machado(Director)
Co-investorsBrace PharmaF-Prime CapitalFoothill VenturesVenture OntarioOrbiMedVersant Ventures
Xpan develops a single universal trocar for minimally invasive surgery (MIS) that accommodates all surgical instruments, aiming to replace traditional trocar access.
BiotechHardwareHealthtechMedical DevicesNobleton
Suresh Pai(Co-Founder & Board Director)inZaid Atto(Founder & CEO)in
Yellowbird Diagnostics develops plug-and-play imaging dyes for common medical imaging procedures, designed to reveal disease markers for earlier diagnosis of conditions affecting the brain, heart, and kidneys.
BiotechHealthtechMedical Devices
Co-investorsFront Row Ventures
Exits · 3
IPOs and acquisitions across the tracked portfolioProfound MedicalNASDAQ: PROFDVS Sciencesacq. by Fluidigm Corp.Fluorinov Pharmaacq. by Trillium Therapeutics
Frequently asked questions
- How many investments has FACIT (Fight Against Cancer Innovation Trust) made?
- FACIT (Fight Against Cancer Innovation Trust) has 53 tracked investments, 2 of which have exited via acquisition or IPO, including 4 dated in the last 24 months.
- What stage does FACIT (Fight Against Cancer Innovation Trust) invest at?
- FACIT (Fight Against Cancer Innovation Trust) invests at the Pre-Seed, Seed, Series A, Series B stages.
- What is FACIT (Fight Against Cancer Innovation Trust)'s typical check size?
- FACIT (Fight Against Cancer Innovation Trust) typically writes checks of $1.1M.
- What sectors does FACIT (Fight Against Cancer Innovation Trust) focus on?
- FACIT (Fight Against Cancer Innovation Trust) focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is FACIT (Fight Against Cancer Innovation Trust) located?
- FACIT (Fight Against Cancer Innovation Trust) is headquartered in Toronto, CA.
- Who does FACIT (Fight Against Cancer Innovation Trust) co-invest with?
- FACIT (Fight Against Cancer Innovation Trust) most often shares deals with Toronto Innovation Acceleration Partners, Creative Destruction Lab (CDL), Venture Ontario, among 23 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.
Panacea Venture is a global investment firm, spun out from Kleiner Perkins, focused on life sciences and healthcare innovation. It invests across geographies and stages, from company formation through expansion and public markets.
Lang Sheng Investment (朗盛投资) is a leading Chinese investment firm focused on the large healthcare sector, with experience in screening, investing in, and supporting medical and health companies.